Xian Deng
Stock Analyst at UBS
(4.54)
# 1,031
Out of 4,698 analysts
174
Total ratings
65.7%
Success rate
17.1%
Average return
Main Sectors:
Stocks Rated by Xian Deng
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARGX argenx SE | Upgraded: Buy | $960 → $1,400 | $1,053.46 | +32.90% | 35 | Aug 26, 2026 | |
| LON: 0QW0 argenx SE | Upgraded: Buy | n/a | $911.30 | - | 14 | Aug 26, 2026 | |
| LON: 0MGB Genmab A/S | Maintained: Buy | kr 2,600 → kr 2,700 | kr 2,197 | +22.89% | 37 | Aug 7, 2026 | |
| LON: 0NZT UCB SA | Maintained: Buy | €330.00 → €310.00 | €220.15 | +40.81% | 24 | Aug 4, 2026 | |
| EPA: IPN Ipsen S.A. | Maintained: Hold | €170.00 | €168.60 | +0.83% | 24 | Aug 3, 2026 | |
| ZLDPF Zealand Pharma A/S | Maintained: Buy | $118 → $113 | $47.64 | +137.97% | 3 | May 8, 2026 | |
| AMS: LKFT Lakefront Biotherapeutics NV | Maintained: Hold | €30.00 | €25.04 | +19.81% | 4 | Apr 1, 2026 | |
| SWX: BIOV BioVersys AG | Initiated Coverage: Buy | CHF 48.00 | CHF 28.20 | +70.21% | 2 | Dec 11, 2025 | |
| SWX: LONN Lonza Group AG | Maintained: Buy | CHF 720.00 → CHF 605.00 | CHF 582.00 | n/a | 12 | Feb 6, 2023 | |
| FRA: MDG1 Medigene AG | Maintained: Buy | €8.00 | €0.02 | n/a | 6 | Aug 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | kr 480.00 → kr 450.00 | kr 561.00 | n/a | 7 | May 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | kr 255.00 | kr 204.89 | n/a | 2 | Feb 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €31.00 | €21.14 | n/a | 4 | Nov 1, 2019 |
argenx SE
Aug 26, 2026
Upgraded: Buy
Price Target: $960 → $1,400
Current: $1,053.46
Upside: +32.90%
argenx SE
Aug 26, 2026
Upgraded: Buy
Price Target: n/a
Current: $911.30
Upside: -
Genmab A/S
Aug 7, 2026
Maintained: Buy
Price Target: kr 2,600 → kr 2,700
Current: kr 2,197
Upside: +22.89%
UCB SA
Aug 4, 2026
Maintained: Buy
Price Target: €330.00 → €310.00
Current: €220.15
Upside: +40.81%
Ipsen S.A.
Aug 3, 2026
Maintained: Hold
Price Target: €170.00
Current: €168.60
Upside: +0.83%
Zealand Pharma A/S
May 8, 2026
Maintained: Buy
Price Target: $118 → $113
Current: $47.64
Upside: +137.97%
Lakefront Biotherapeutics NV
Apr 1, 2026
Maintained: Hold
Price Target: €30.00
Current: €25.04
Upside: +19.81%
BioVersys AG
Dec 11, 2025
Initiated Coverage: Buy
Price Target: CHF 48.00
Current: CHF 28.20
Upside: +70.21%
Lonza Group AG
Feb 6, 2023
Maintained: Buy
Price Target: CHF 720.00 → CHF 605.00
Current: CHF 582.00
Upside: n/a
Medigene AG
Aug 4, 2022
Maintained: Buy
Price Target: €8.00
Current: €0.02
Upside: n/a
May 26, 2020
Downgraded: Hold
Price Target: kr 480.00 → kr 450.00
Current: kr 561.00
Upside: n/a
Feb 17, 2020
Maintained: Buy
Price Target: kr 255.00
Current: kr 204.89
Upside: n/a
Nov 1, 2019
Maintained: Buy
Price Target: €31.00
Current: €21.14
Upside: n/a